DelveInsight's ROS1 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, ...

No writing assistance was utilized in the production of this manuscript. Tyrosine kinase inhibitors (TKIs) are used for the targeted treatment of cancer. TKIs produce a range of serious adverse ...

As with most other recent IPOs in the biotech sector, ArriVent is sitting on a late-stage drug candidate – furmonertinib – a third-generation EGFR tyrosine kinase inhibitor designed to ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent ...

Cisbio's HTRF® KinEASE™ assay for screening serine/threonine kinases now extends to tyrosine kinases (TK ... trend toward screening new protein kinase inhibitors of various kinases for ...

Noah S. Kalman, MD, MBA, discusses the most common types of thyroid cancer and their respective prognoses.

Researchers sought to determine whether a low dose of bosutinib followed by escalation would be effective for patients with CML.

The leading Janus Kinase Inhibitor Companies such as Incyte Corporation, Celon Pharma, Aclaris Therapeutics, Sareum, Takeda, ...

With over 15 years of experience in kinase drug discovery, DiscoverX offers the largest collection of nearly 500 biochemical and cell-based kinase assays. KINOMEscan® technology, our novel kinase ...